NYT, No Need to Analyze

08 December 2008 By Capital Gainer 1

Sometimes there is no need to analyze a stock:

The New York Times Company plans to borrow up to $225 million against its mid-Manhattan headquarters building, to ease a potential cash flow squeeze as the company grapples with tighter credit and shrinking profits. [Read]

The New York Time Company (NYT) is going to borrow against an asset with tangible value to spend on an asset that is, without a doubt, of declining value in a dying industry, an asset that is a cash hungry monster.

What would be the reason to invest in a company with management making these types of decisions?

PN: $7.79

1 comments on NYT, No Need to Analyze

  1. Anonymous
    Mon, 02/09/2009 - 13:27

    Arena Pharmaceuticals, Inc. (ARNA)